Skip to main content

Table 3 Association between the presence or the absence of Metabolic syndrome and Hyperhomocysteinemia and LVH

From: Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese

 UnadjustedModel 1Model 2Model 3
LVMIOR95%CIOR95%CIOR95%CIOR95%CI
Non-MetS & normal Hcyref ref ref ref 
HHcy & Non-MetS1.208*1.049–1.3911.201#1.025–1.4071.201#1.025–1.4071.175#1.002–1.377
Normal Hcy & MetS2.300*2.006–2.6381.820*1.575–2.1031.817*1.572–2.1001.615*1.393–1.873
MetS & HHcy2.284*1.957–2.6661.929*1.627–2.2861.921*1.620–2.2781.628*1.364–1.944
LVMH2.7OR95%CIOR95%CIOR95%CIOR95%CI
Non-MetS & normal Hcyref ref ref   
HHcy & Non-MetS1.760*1.494–2.0741.291#1.082–1.5411.291#1.081–1.5411.248#1.044–1.492
Normal Hcy & MetS3.261*2.787–3.8152.974*2.528–3.4992.951*2.508–3.4732.567*2.174–3.032
MetS & HHcy4.143*3.492–4.9153.013*2.519–3.6032.960*1.084–3.5422.433*2.019–2.932
  1. Model1 adjusted for gender, age, current smoking, current drinking, activity, education
  2. Model2 adjusted for gender, age, current smoking, current drinking, activity, education, high LDL-C
  3. Model3 adjusted for gender, age, current smoking, current drinking, activity, education, high LDL-C, hyperuricemia and medication treatment of hypertension or dyslipidemia
  4. * means P < 0.001,# means P < 0.05
  5. Abbreviations: LVH left ventricular hypertrophy, MetS metabolic syndrome